Table 2.
At 5 years | Low-risk | Intermediate-risk | High-risk |
---|---|---|---|
FFBF(%) with 95%CI | 100 (100–100) vs 96.8 (94.5–98.2), p=0.3 |
88.6 (82.2–92.8) vs 89.0 (85.1–91.9), p=0.5 |
82.5 (62.1–92.5) vs 67.0 (50.8–78.9), p=0.2 |
FFDM (%) with 95%CI | 99.4 (96.2–99.9) vs 99.5 (97.9–99.9), p=0.2 |
96.7 (92.2–98.7) vs 96.4 (94.0–97.9), p=0.9 |
85.6 (64.9–94.5) vs 88.4 (73.0–95.3), p=0.9 |
CSS (%) with 95%CI | 100 (100–100) vs 100 (100–100), p=0.4 |
100 (100–100) vs 98.4 (95.8–99.4), p=0.6 |
100 (100–100) vs 98.4 (89.6–99.8), p=0.8 |
OS (%) with 95%CI | 95.2 (89.5–97.8) vs 97.6 (95.5–98.8), p=0.2 |
89.6 (83.4–93.6) vs 90.0 (86.4–92.7), p=0.2 |
91.5 (70.1–97.8) vs 95.4 (81.9–98.9), p=0.4 |
Abbreviations: FFBF= freedom from biochemical failure; FFDM=freedom from distant metastasis; CSS=cancer-specific survival; OS=overall survival; CI: confidence interval